Daiwa Securities Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-326
| Closed | -$9K | – | 1313 |
|
2024
Q3 | $9K | Hold |
326
| – | – | ﹤0.01% | 1136 |
|
2024
Q2 | $8K | Hold |
326
| – | – | ﹤0.01% | 1168 |
|
2024
Q1 | $7K | Hold |
326
| – | – | ﹤0.01% | 1180 |
|
2023
Q4 | $6K | Hold |
326
| – | – | ﹤0.01% | 1186 |
|
2023
Q3 | $5K | Hold |
326
| – | – | ﹤0.01% | 1155 |
|
2023
Q2 | $8K | Hold |
326
| – | – | ﹤0.01% | 1141 |
|
2023
Q1 | $8K | Hold |
326
| – | – | ﹤0.01% | 1115 |
|
2022
Q4 | $5K | Buy |
326
+59
| +22% | +$905 | ﹤0.01% | 1150 |
|
2022
Q3 | $5K | Hold |
267
| – | – | ﹤0.01% | 1154 |
|
2022
Q2 | $5K | Hold |
267
| – | – | ﹤0.01% | 1162 |
|
2022
Q1 | $7K | Hold |
267
| – | – | ﹤0.01% | 1148 |
|
2021
Q4 | $7K | Hold |
267
| – | – | ﹤0.01% | 1163 |
|
2021
Q3 | $9K | Buy |
267
+126
| +89% | +$4.25K | ﹤0.01% | 1145 |
|
2021
Q2 | $4K | Hold |
141
| – | – | ﹤0.01% | 1088 |
|
2021
Q1 | $4K | Hold |
141
| – | – | ﹤0.01% | 1092 |
|
2020
Q4 | $3K | Sell |
141
-279
| -66% | -$5.94K | ﹤0.01% | 1089 |
|
2020
Q3 | $5K | Hold |
420
| – | – | ﹤0.01% | 1083 |
|
2020
Q2 | $6K | Hold |
420
| – | – | ﹤0.01% | 1084 |
|
2020
Q1 | $6K | Hold |
420
| – | – | ﹤0.01% | 1082 |
|
2019
Q4 | $11K | Sell |
420
-46
| -10% | -$1.21K | ﹤0.01% | 1043 |
|
2019
Q3 | $13K | Hold |
466
| – | – | ﹤0.01% | 1007 |
|
2019
Q2 | $13K | Hold |
466
| – | – | ﹤0.01% | 1028 |
|
2019
Q1 | $15K | Buy |
466
+83
| +22% | +$2.67K | ﹤0.01% | 995 |
|
2018
Q4 | $11K | Hold |
383
| – | – | ﹤0.01% | 983 |
|
2018
Q3 | $18K | Hold |
383
| – | – | ﹤0.01% | 994 |
|
2018
Q2 | $14K | Hold |
383
| – | – | ﹤0.01% | 1020 |
|
2018
Q1 | $11K | Buy |
+383
| New | +$11K | ﹤0.01% | 1015 |
|
2014
Q2 | – | Sell |
-90,000
| Closed | -$3.08M | – | 914 |
|
2014
Q1 | $3.08M | Buy |
+90,000
| New | +$3.08M | 0.02% | 195 |
|